|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Rosiglitazone is a safe and effective treatment option of new-onset diabetes menitus after renal transplantation显示文摘 | Pietruck F Kribben A Van TN | 2005 | Transpl Int2005，80，： | 1 |
| 2 | Definition and risk factors of rapidly declining residual renal function in per- itoneal dialysis: an observational study显示文摘 | Herget-Rosenthal S von Ostrowski M Kribben A | 2012 | Kidney Blood Press Res2012，35，4： | 1 |
| 3 | Definition and risk factors of rapidly declining residual renal function in peritoneal dialysis:an observational study显示文摘 | Herget-Rosenthal S von Ostrowski M Kribben A | 2012 | Kidney Blood Press Res2012，35，4： | 1 |
| 4 | Extracoporeal liver support by fractionated plasma separation and adsorption(Prometheus)in patients with acute-on-chronic liver failure(Helios study):a prospective randomized controlled multicenter study显示文摘 | Rifai K Kribben A Gerken G | | 0，，： | 1 |
| 5 | Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure显示文摘 | Kribben A Gerken G Haag S | 2012 | Gastroenterology2012，142，： | 1 |
| 6 | Posttraumatic stress disorder in hemodialysis patients显示文摘 | Tagay S kribben A Hohenstein A | 2007 | Am J Kidney Dis2007，50，： | 1 |
| 7 | Contrast media induced nephropathy:defi- nition, incidence, outcome, pathophysiology, risk factors and preven- tion 显示文摘 | Feldkamp T Kribben A | 2008 | Minerva Medica2008，99，2： | 1 |
| 8 | Rosiglitazone is a safe and ef- fective treatment option of new-onset diabetes mellitus after renal transplantation 显示文摘 | Pietruck F Kribben A Van TN | 2005 | Transpl Int2005，18，4： | 1 |
| 9 | Arterial compliance (stiffness) as a marker of subclinical atherosclerosis显示文摘 | Nurnberger J Kribben A Philipp T | 2007 | Herz2007，32，5： | 1 |
| 10 | Rosiglitazone is a safe and effective treatment option of newonset diabetes mellitus after renal transplantation显示文摘 | Pietruck F Kribben A Ngo Van T | 2005 | Transpl Int2005，18，3： | 1 |
| 11 | CD134 expression on CD4^ + T cells is associated with nephritis and disease aetivity in patients with systemic lupus erythematosus 显示文摘 | Patschan S Dolff S Kribben A | 2006 | Clin Exp Immunol2006，145，2： | 1 |
| 12 | CD134 expression on CD4+ T ceils is associated with nephritis and disease activity in patients with systemic lupus erythematosus显示文摘 | Patschan S Dolff S Kribben A | 2006 | Clin Exp Immunol2006，145，2： | 1 |
| 13 | Cognitive impairment in chronic kidney disease: clinical findings ,risk fac- tors and consequences for patient care显示文摘 | Hermann DM Kribben A Bruck H | 2014 | J Neural Transm(Vienna)2014，121，6： | 1 |
| 14 | Contrast media induced nephropa- thy: definition, incidence, outcome, pathophysiology, risk factors and prevention 显示文摘 | Feldkamp T Kribben A | 2008 | Minerva Med2008，99，2： | 1 |
| 15 | Rosiglitazone is a safe and effective treatment option of new-onset diabetes mellitus after renal transplantation 显示文摘 | Pietruck F Kribben A Van TN | 2005 | Transpl Int2005，18，4： | 1 |
| 16 | Acute kidney injury 显示文摘 | Feldkamp T Bienholz A Kribben A | 2011 | Dtsch Med Wochenschr2011，136，5： | 1 |
| 17 | Rosiglitazone is a safe and effective treatment option of new-onset diabetes mellitus after renal transplantation显示文摘 | Pietruck F Kribben A Van TN | 2005 | Transplantation International2005，18，4： | 1 |
| 18 | Alleviation of fatty acid and hypoxia reoxygenation induced proximal tubule deenergization by ADP/ATP cartier inhibition and glutamate 显示文摘 | Feldkamp T Kribben A Roeser N F | 2007 | Am J Physiol Renal Physiol2007，292，5： | 1 |
| 19 | Contrast media induced nephr opathy idefinition,incidence,outcome,pathophysiology,risk factors and prevention 显示文摘 | Feldkamp T Kribben A | 2008 | Minerva Med2008，99，2： | 1 |
| 20 | Contrast media induced nephropathy:Definition,incidence,outcome,pathophysiology,risk factors and prevention显示文摘 | Feldkamp T Kribben A | 2008 | Minerva Med2008，99，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员